论文部分内容阅读
Rapamycin and its derivatives (rapalogs) , a group of allosteric inhibitors of mammalian target of rapamycin (mTOR), have been actively tested in a variety of cancer clinical trials, and some have been approved by the Food and Drug Administration for the